On Day 1 of the Hamps Bio IPO, the latest grey market premium (GMP) signals interest in the offering, although specific subscription figures and the anticipated listing date are awaited. Investors are keenly monitoring the IPO's performance amid market trends, and updates on subscription status will provide insight into demand.

With a 6.48 times subscription rate, Hamps Bio's initial public offering (IPO) garnered a lot of interest when it began on December 13. 11.76 times as many retail investors subscribed. The company intends to list on December 20 and is looking to raise ₹6.22 crore for its FMCG sector.

Update on Hamps Bio's IPO: Hamps Bio's initial public offering (IPO), which went up for bid on Friday, December 13. Bids will be accepted until December 17, 2024. The public issue attracted significant investor interest, as seen by the Hamps Bio IPO subscription status, which, according to exchange statistics, was subscribed 8.79 times by 4:00 p.m. on the first day of bidding.

Demand was strong for the retail investor segment, as seen by 15.83 times as many subscriptions, compared to 1.75 times for the non-institutional investor (NII) category. Interestingly, qualified institutional buyers (QIBs) were not given any money. The IPO revenues will be used by the company to cover basic corporate expenses, improve brand exposure and awareness, and buy plant and machinery for its FMCG segment.

Details of the Hamps Bio IPO issue 1. Date of the Hamps Bio IPO: Subscriptions for the issue went live on Friday, December 13, and it will end on Tuesday, December 17.

2. Hamps Bio IPO Price: ₹51 per equity share is the set price range for the public offering.

3. Hamps Bio IPO Size: By issuing a new 12.22 lakh shares, the business hopes to raise ₹6.22 crore.

4. Hamps Bio IPO Lot Size: Retail investors must deposit a minimum of ₹1,02,000, and the IPO lot size is set at 2000 shares.

5. Hamps Bio IPO reservation: 5.79 lakh shares are available to regular investors and non-institutional buyers in the IPO.

6. Date of Hamps Bio IPO allotment: Wednesday, December 18 is the date of the IPO allotment. By Thursday, December 19, investors who obtain an allocation will be able to view the shares in their demat accounts; those who do not will process their refunds that same day.

7. Hamps Bio IPO listing: On Friday, December 20, the SME IPO is expected to list on the BSE SME.

8. IPO GMP for Hamps Bio: Market sources indicate that the IPO GMP for Rajputana Biodiesel is ₹21 today, indicating that the company might list ₹21 higher than the issue price of 51, which is at ₹72.

9. Lead manager and registrar for the Hamps Bio IPO book-running: Bigshare Services Pvt. Ltd. is the issue's registrar, and Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. is the book-running lead manager for the Hamps Bio IPO. Pure Broking is the market maker for the Hamps Bio IPO.

10. Business overview of Hamps Bio: The company manufactures freeze-dried and frozen products (referred to as the "FDFP" or "FMCG Division"), such as fruits, vegetables, herbs, and flowers, and markets and distributes pharmaceutical formulation products (referred to as "Pharma") in a variety of dosages, such as tablets, syrups, capsules, injectables, oil, gel, and powder used as medicine and nutrition supplements.

As of March 31, 2024, it offers its goods through e-commerce sites like Flipkart, Jio Mart, Amazon.com, Amazon.ca, and Amazon.eu, as well as networks of more than 50 wholesalers. According to the company's DRHP report, it sells its pharmaceutical products mainly in eight states and union territories, and our FDFP products mainly in four nations and twenty-two states and union territories.